New Insight in Hyperinsulinism/Hyperammonemia Syndrome by Magnetic Resonance Imaging and Spectroscopy.
Karim GarianiAntoine KlauserMaria Isabel VargasFrançois LazeyrasChristel TranPublished in: Brain sciences (2022)
Hyperinsulinism/hyperammonemia syndrome (HI/HA) is an autosomal dominant disorder caused by monoallelic activating mutations in the glutamate dehydrogenase 1 ( GLUD1 ) gene. While hyperinsulinism may be explained by a reduction in the allosteric inhibition of GLUD1 , the pathogenesis of HA in HI/HA remains uncertain; interestingly, HA in the HI/HA syndrome is not associated with acute hyperammonemic intoxication events. We obtained a brain magnetic resonance (MR) in a woman with HI/HA syndrome with chronic asymptomatic HA. On MR spectroscopy, choline and myoinositol were decreased as in other HA disorders. In contrast, distinct from other HA disorders, combined glutamate and glutamine levels were normal (not increased). This observation suggests that brain biochemistry in HI/HA may differ from that of other HA disorders. In HI/HA, ammonia overproduction may come to the expense of glutamate levels, and this seems to prevent the condensation of ammonia with glutamate to produce glutamine that is typical of the other HA disorders. The absence of combined glutamate and glutamine elevation might be correlated to the absence of acute cerebral ammonia toxicity.
Keyphrases
- magnetic resonance
- magnetic resonance imaging
- case report
- contrast enhanced
- liver failure
- computed tomography
- gene expression
- signaling pathway
- intensive care unit
- multiple sclerosis
- dna methylation
- room temperature
- subarachnoid hemorrhage
- drug induced
- cerebral ischemia
- acute respiratory distress syndrome
- ionic liquid
- mechanical ventilation